| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
251,510,000 |
| Market
Cap: |
135.55(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$414.13 - $547.8 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 17 |
| Guru Rank Value : 22.1 |
| Guru Occurances : 4 |
|
|
|
|
|
| |
|
Company Profile Elevance Health is an insurance holding company. Co. is a health benefits company, serving medical members through its affiliated health plans. Co. has four segments: Commercial and Specialty Business, which provides fully-insured health products, managed care services; Government Business, which includes Medicare and Medicaid businesses, its subsidiary, National Government Services, and services provided to the federal government in connection with its Federal Health Products and Services business; IngenioRx, which includes its pharmacy benefit management business; and Other, which includes Diversified Business Group, which is its integrated health services business.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
20,310 |
50,998 |
52,427 |
76,167 |
| Total Sell Value |
$10,832,155 |
$26,097,504 |
$26,775,666 |
$37,652,093 |
| Total People Sold |
1 |
6 |
7 |
8 |
| Total Sell Transactions |
2 |
7 |
10 |
13 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Penczek Ronald W |
SVP, Chief Accounting Officer |
• • – |
2017-11-07 |
4 |
OE |
$131.80 |
$144,704 |
D/D |
978 |
1,983 |
|
- |
|
| Swedish Joseph |
Chair, President & CEO |
• • – |
2017-11-01 |
4 |
AS |
$209.47 |
$4,433,059 |
D/D |
(21,125) |
66,543 |
|
- |
|
| Swedish Joseph |
Chair, President & CEO |
• • – |
2017-11-01 |
4 |
OE |
$67.44 |
$1,424,670 |
D/D |
21,125 |
87,668 |
|
- |
|
| Mccarthy Gloria M |
EVP & Chief Transformation Off |
• • – |
2017-10-03 |
4 |
D |
$193.23 |
$17,004 |
D/D |
(88) |
44,996 |
|
- |
|
| Samitt Craig E |
EVP & Chief Clinical Officer |
• • – |
2017-10-02 |
4 |
D |
$191.11 |
$71,666 |
D/D |
(375) |
8,994 |
|
- |
|
| Swedish Joseph |
Chair, President & CEO |
• • – |
2017-10-02 |
4 |
AS |
$190.54 |
$4,027,086 |
D/D |
(21,125) |
66,543 |
|
- |
|
| Swedish Joseph |
Chair, President & CEO |
• • – |
2017-10-02 |
4 |
OE |
$67.44 |
$1,424,670 |
D/D |
21,125 |
87,668 |
|
- |
|
| Wolf Jacquelyn H |
EVP & Chief HR Officer |
• • – |
2017-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
950 |
950 |
|
- |
|
| Swedish Joseph |
Chair, President & CEO |
• • – |
2017-09-01 |
4 |
AS |
$196.45 |
$4,161,594 |
D/D |
(21,125) |
66,543 |
|
- |
|
| Swedish Joseph |
Chair, President & CEO |
• • – |
2017-09-01 |
4 |
OE |
$67.44 |
$1,424,670 |
D/D |
21,125 |
87,668 |
|
- |
|
| Zielinski Thomas C |
EVP & General Counsel |
• • – |
2017-08-10 |
4 |
S |
$189.85 |
$1,745,574 |
D/D |
(9,127) |
17,444 |
|
- |
|
| Zielinski Thomas C |
EVP & General Counsel |
• • – |
2017-08-10 |
4 |
OE |
$108.35 |
$988,910 |
D/D |
9,127 |
26,571 |
|
- |
|
| Hill Julie A |
Director |
• • – |
2017-08-10 |
4 |
S |
$190.80 |
$99,979 |
D/D |
(524) |
36,924 |
|
- |
|
| Griffin Brian T |
EVP & President, CSBD |
• • – |
2017-08-03 |
4 |
D |
$191.44 |
$40,777 |
D/D |
(213) |
20,078 |
|
- |
|
| Penczek Ronald W |
SVP, Chief Accounting Officer |
• • – |
2017-06-07 |
4 |
S |
$187.46 |
$162,528 |
D/D |
(867) |
1,005 |
|
- |
|
| Penczek Ronald W |
SVP, Chief Accounting Officer |
• • – |
2017-06-07 |
4 |
OE |
$146.93 |
$127,388 |
D/D |
867 |
1,872 |
|
- |
|
| Zielinski Thomas C |
EVP & General Counsel |
• • – |
2017-06-02 |
4 |
D |
$187.58 |
$576,058 |
D/D |
(3,071) |
17,444 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• • – |
2017-06-01 |
4 |
D |
$187.69 |
$54,618 |
D/D |
(291) |
19,222 |
|
- |
|
| Peru Ramiro G |
Director |
• • – |
2017-05-30 |
4 |
AS |
$181.58 |
$486,816 |
D/D |
(2,681) |
13,571 |
|
- |
|
| Hill Julie A |
Director |
• • – |
2017-05-24 |
4 |
S |
$180.56 |
$100,211 |
D/D |
(555) |
37,448 |
|
- |
|
| Hill Julie A |
Director |
• • – |
2017-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
990 |
38,003 |
|
- |
|
| Dixon Robert L Jr |
Director |
• • – |
2017-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
990 |
9,985 |
|
- |
|
| Hay Lewis III |
Director |
• • – |
2017-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
990 |
6,923 |
|
- |
|
| Tallett Elizebeth E |
Director |
• • – |
2017-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
990 |
6,308 |
|
- |
|
| Clark R Kerry |
Director |
• • – |
2017-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
990 |
5,056 |
|
- |
|
634 Records found
|
|
Page 16 of 26 |
|
|
2.10 (0.39%) 
